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Recombinant human G1 (rhG1) induced arthritis (GIA) model resembles human rheumatoid 
arthritis (RA) both in immunological characteristics and clinical parameters. Immunization of 
BALB/c mice with rhG1 domain of human proteoglycan aggrecan induces arthritis. T cells are 
involved in the pathogenesis of arthritis; their activation is regulated by ZAP-70, a key molecule in 
T cell receptor signaling.  
 
The aim of our study was to assess the effect of partial ZAP-70 deficiency on autoimmune arthritis 
in the GIA model.  
 
Wild-type BALB/c (WT) and ZAP-70 heterozygous knockout (ZAP-70
+/-
) mice were immunized 
with rhG1 side-by-side. Surprisingly, partial ZAP-70 deficiency did not inhibit the development of 
GIA; moreover, the arthritis was more severe in ZAP-70
+/- 
mice than in WT as assessed by the 
physical scoring system. Luminescence imaging confirmed the increased inflammatory activity in 
affected limbs of ZAP-70
+/- 
mice compared to WT animals. There was a clear correlation between 
the results of the functional test (hanging time measurements) and the clinical scores. Alterations in 
the physical performance preceded the clinical onset of arthritis. Investigation of the T cell 
mediated immune response indicated decreased T cell proliferation and IL-4,-6 production 
accompanied by significant IL-17, IFNγ and TNFα production measured from in vitro splenocyte 
cultures.  
 
Contrary to our expectations partial deficiency of ZAP-70 did not ameliorate the severity of arthritis 
in GIA model, which may be due to alterations in T cell activation and apoptosis. 
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